Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Ding, Y. Ge, Y.

Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Kapoula, G. V. Vennou, K. E. Bagos, P. G.

Influenza and Pneumococcal Vaccination and the Risk of COVID-19: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Influenza
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Wu, H. H. L. Shenoy, M. Kalra, P. A. Chinnadurai, R.

Intrinsic Kidney Pathology in Children and Adolescents Following COVID-19 Vaccination: A Systematic Review

  • Children
  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Hameed, I. Khan, M. O. Nusrat, K. Mahmood, S. Nashit, M. Malik, S. Siddiqui, O. M. Samad, S. A. Marsia, S. Usman, M. S. Siddiqi, T. J.

Is it safe and effective to administer COVID-19 vaccines during pregnancy? A systematic review and meta-analysis

  • Adults
  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Mirmosayyeb, O. Moases Ghaffary, E. Mazdak, M. Bagheri, Z. Bagherieh, S. Shaygannejad, V.

Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Cascio Rizzo, A. Giussani, G. Agostoni, E. C.

Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Wang, Y. Zhang, X.

Key factors influencing paediatric COVID-19 vaccine hesitancy: a brief overview and Decision-making Trial and Evaluation Laboratory analysis

  • Parents/caregivers
  • Children
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Talasaz, A. H. Sadeghipour, P. Mehdizadeh, K. Khoshnam Rad, N. Bikdeli, B. Lip, G. Y. Harenberg, J.

Knowledge gaps for prophylactic antithrombotic agents use in patients with COVID-19: Insights on new variants, vaccination and emerging antivirals

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bachour, Y. Bekkenk, M. W. Rustemeyer, T. Kadouch, J. A.

Late inflammatory reactions (LIRs) in patients with soft tissue fillers after SARS-CoV-2 infection and vaccination: A systematic review of the literature

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Feschuk, A. M. Green, M. Kashetsky, N. Maibach, H. I.

Lichen planus following SARS-CoV-2 infection and vaccination? A systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...